265 related articles for article (PubMed ID: 28651565)
1. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
3. Prokinetics for functional dyspepsia.
Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Leontiadis GI; Moayyedi P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009431. PubMed ID: 30335201
[TBL] [Abstract][Full Text] [Related]
4. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis.
Qi Q; Wang N; Liu H; Li Y
BMC Gastroenterol; 2023 Oct; 23(1):370. PubMed ID: 37907846
[TBL] [Abstract][Full Text] [Related]
5. Itopride therapy for functional dyspepsia: a meta-analysis.
Huang X; Lv B; Zhang S; Fan YH; Meng LN
World J Gastroenterol; 2012 Dec; 18(48):7371-7. PubMed ID: 23326147
[TBL] [Abstract][Full Text] [Related]
6. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
Sun J; Yuan YZ; Holtmann G
Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
[TBL] [Abstract][Full Text] [Related]
7. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
[TBL] [Abstract][Full Text] [Related]
8. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants].
Hongo M; Satake M
Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811
[No Abstract] [Full Text] [Related]
9. Risk of domperidone induced severe ventricular arrhythmia.
Song BG; Lee YC; Min YW; Kim K; Lee H; Son HJ; Rhee PL
Sci Rep; 2020 Jul; 10(1):12158. PubMed ID: 32699312
[TBL] [Abstract][Full Text] [Related]
10. Acupuncture for functional dyspepsia.
Lan L; Zeng F; Liu GJ; Ying L; Wu X; Liu M; Liang FR
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008487. PubMed ID: 25306866
[TBL] [Abstract][Full Text] [Related]
11. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia.
Lim HC; Lee SI; Chen JD; Park H
World J Gastroenterol; 2012 Nov; 18(41):5948-56. PubMed ID: 23139612
[TBL] [Abstract][Full Text] [Related]
12. Mosapride treatment for functional dyspepsia: a meta-analysis.
Bang CS; Kim JH; Baik GH; Kim HS; Park SH; Kim EJ; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ
J Gastroenterol Hepatol; 2015 Jan; 30(1):28-42. PubMed ID: 25041564
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
Amarapurkar DN; Rane P
J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
[TBL] [Abstract][Full Text] [Related]
14. Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.
Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Lacy BE; Andrews CN; Leontiadis GI; Moayyedi P
Am J Gastroenterol; 2019 Feb; 114(2):233-243. PubMed ID: 30337705
[TBL] [Abstract][Full Text] [Related]
15. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
[TBL] [Abstract][Full Text] [Related]
17. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study.
Hallerbäck BI; Bommelaer G; Bredberg E; Campbell M; Hellblom M; Lauritsen K; Wienbeck M; Holmgren LL
Aliment Pharmacol Ther; 2002 May; 16(5):959-67. PubMed ID: 11966505
[TBL] [Abstract][Full Text] [Related]
18. [Prokinetics in childhood].
Gottrand F
Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
[No Abstract] [Full Text] [Related]
19. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
Sawant P; Das HS; Desai N; Kalokhe S; Patil S
J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
